ArticleCancer research communications2024

A Precision Engineered Interleukin-2 for Bolstering CD8+ T- and NK-cell Activity without Eosinophilia and Vascular Leak Syndrome in Nonhuman Primates.

Lina Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.